Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.
Toronto General Hospital Research Institute, University Health Network (UHN), Toronto, ON, Canada; Institute for Health Policy, Management, and Evaluation, University of Toronto, ON, Canada.
J Cardiovasc Comput Tomogr. 2023 Nov-Dec;17(6):373-383. doi: 10.1016/j.jcct.2023.08.010. Epub 2023 Aug 25.
Different methodologies have been used to assess the role of AV calcification (AVC) on TAVI outcomes. This systematic review aims to describe the burden of AVC, synthesize the different methods of calcium score quantification, and evaluate the impact of AVC on outcomes after TAVI. We included studies of TAVI patients who had reported AV calcium scoring by contrast-enhanced multidetector CT and the Agatston method. The impact of calcification on TAVI outcomes without restrictions on follow-up time or outcome type was evaluated. Results were reported descriptively, and a meta-analysis was conducted when feasible. Sixty-eight articles were included, with sample sizes ranging from 23 to 1425 patients. Contrast-enhanced calcium scoring was reported in 30 studies, calcium volume score in 28 studies, and unique scoring methods in two. All studies with calcium volume scores had variable protocols, but most utilized a modified Agatston method with variable attenuation threshold values of 300-850 HU. Eight studies used the Agatston method, with the overall mean AV calcium score in studies published from 2010 to 2012 of 3342.9 AU [95%CI: 3150.4; 3535.4, I2 = 0%]. The overall mean score was lower and heterogenous in studies published from 2014 to 2020 (2658.9 AU [95% CI: 2517.3; 2800.5, I2 = 79%]. Most studies reported a positive association between calcium burden and increased risk of adverse outcomes, including implantation of permanent pacemaker (7/8 studies), paravalvular leak (13/13 studies), and risk of aortic rupture (2/2 studies). AVC quantification methodology with contrast-enhanced CT is still variable. AVC negatively impacts TAVI outcomes independently of the quantification method.
已经使用了不同的方法来评估房室瓣钙化(AVC)在 TAVI 结果中的作用。本系统综述旨在描述 AVC 的负担,综合钙评分量化的不同方法,并评估 AVC 对 TAVI 后结果的影响。我们纳入了报告经对比增强多排 CT 和 Agatston 法进行 AV 钙评分的 TAVI 患者的研究。评估了钙化对 TAVI 结果的影响,而不受随访时间或结果类型的限制。结果以描述性方式报告,如果可行,则进行荟萃分析。共纳入 68 篇文章,样本量范围为 23 至 1425 例患者。30 项研究报告了增强钙评分,28 项研究报告了钙体积评分,两项研究报告了独特的评分方法。所有具有钙体积评分的研究均有不同的方案,但大多数研究采用了改良的 Agatston 法,衰减阈值值为 300-850 HU 不等。8 项研究使用了 Agatston 法,2010 年至 2012 年发表的研究中 AV 钙的平均总分为 3342.9 AU [95%CI: 3150.4; 3535.4,I2=0%]。2014 年至 2020 年发表的研究中,平均总分为 2658.9 AU [95% CI: 2517.3; 2800.5,I2=79%],且得分较低且存在异质性。大多数研究报告钙负荷与不良结局风险增加之间存在正相关,包括永久性起搏器植入(7/8 项研究)、瓣周漏(13/13 项研究)和主动脉破裂风险(2/2 项研究)。增强 CT 评估 AVC 的方法仍然存在差异。AVC 对 TAVI 结果的影响独立于定量方法。